Orchestra BioMed (Series A)
Funding Details
Awarder
Inbox
Date Award
August 14, 2025
Vertical
Biomedical
Funding Amount
$70,000,000
Company Info
Organizations Involved
Ligand Pharmaceuticals, Medtronic, Terumo
Market
Cardiology
Location
New Hope, Pennsylvania, USA
Coinvestors
Ligand Pharmaceuticals, Medtronic
Company Description

Orchestra BioMed is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships with leading medical device companies. Orchestra BioMed's partnership-enabled business model focuses on forging strategic collaborations with leading medical device companies to drive successful global commercialization of products it develops.

Links